(Q28259198)

https://api.crossref.org/works/10.1517/13543784.6.10.1351

kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression

21 April 2017

1 reference

https://api.crossref.org/works/10.1517/13543784.6.10.1351

The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties

21 April 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted-ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid .kappa. agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Pharmacological profile of PD 117302, a selective kappa-opioid agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

(2S)-1-(Arylacetyl)-2-(aminomethyl)piperidine derivatives: novel, highly selective .kappa. opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Pharmacological properties of R-84760, a novel kappa-opioid receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

A series of novel, highly potent and selective agonists for the kappa-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

A novel series of potent and selective agonists at the opioid kappa-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

21 January 2018

An opioid benzodiazepine

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Aspartic acid conjugates of 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1(3-aminophenyl)-2-(1-pyrrolidi nyl) ethyl]acetamide: kappa opioid receptor agonists with limited access to the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Effects of fedotozine on gastrointestinal motility in dogs: mechanism of action and related pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

A method to determine the ability of drugs to diffuse through the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Gender difference in analgesic response to the kappa-opioid pentazocine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Kappa-opioids produce significantly greater analgesia in women than in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Pharmacology and mechanisms of opioid analgesic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Opioid agonists and antagonists: an evaluation of their peripheral actions in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Role of opioids in peripheral analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Spinal opioid systems in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Abdominal pain and irritable bowel syndrome in adolescents: a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Dysmotility of the small intestine in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

The effect of intrathecal opioid-receptor agonists on visceral noxious stimulation in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Characterisation of kappa-opioid binding sites in rat and guinea-pig spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Opioid mechanisms controlling renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51,599), in rats with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Mechanism of diuretic action of spiradoline (U-62066E)-a kappa opioid receptor agonist in the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Protection from cerebral ischemia by U-50,488E, a specific kappa opioid analgesic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Quantitative analysis of effects of kappa-opioid agonists on postischemic hippocampal CA1 neuronal necrosis in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Neuroprotective actions of GR89696, a highly potent and selective κ-opioid receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: effect of pretreatment with enadoline (a kappa receptor agonist).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Distribution of effects of the kappa-opioid agonist CI-977 on cerebral glucose utilization in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Opioid receptors influence spinal cord electrical activity and edema formation following spinal cord injury: experimental observations using naloxone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

The kappa opioid receptor and food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Selective cyclooxygenase-2 inhibitors: pharmacology, clinical effects and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351

Structurally novel group of ligands selective for kappa opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.10.1351